Inventor · disambiguated record
Jeffrey T. Mihalic
Also filed as: MIHALIC JEFFREY · MIHALIC JEFFREY T · MIHALIC JEFFREY THOMAS
32 granted patents·13 pending applications·368 citations·filing 2001–2023
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US10344016B2Bromotriazole intermediatesAMGEN INC·Filed 2018·Granted Jul 9, 2019·8 cites·5 claims
- 0298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0397US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0497US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0597US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0697US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0797US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0896US7148259B1Antibacterial agentsAMGEN INC·Filed 2006·Granted Dec 12, 2006·23 cites·10 claims
- 0995US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 1095US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1195US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1294US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 1394US6780858B2Antibacterial agentsTULARIK INC·Filed 2001·Granted Aug 24, 2004·35 cites·25 claims
- 1493US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 1592US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 1691US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 1790US7045527B2Piperidine derivativesAMGEN INC·Filed 2003·Granted May 16, 2006·39 cites·25 claims
- 1889US7799795B2Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disordersAMGEN INC·Filed 2006·Granted Sep 21, 2010·21 cites·17 claims
- 1988US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 2088US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 2187US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 2286US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 2380US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2480US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 2580US7572783B2Substituted benzofused heterocyclesAMGEN INC·Filed 2005·Granted Aug 11, 2009·3 cites·20 claims
- 2680US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2777US7271271B2Imidazolo-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted Sep 18, 2007·3 cites·14 claims
- 2874US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2971US6809104B2Fused heterocyclic compoundsTULARIK INC·Filed 2002·Granted Oct 26, 2004·4 cites·38 claims
- 3070US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 3167US7053234B2Antibacterial agentsAMGEN INC·Filed 2004·Granted May 30, 2006·2 cites·5 claims
- 3267US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3464US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3563US7253179B2Fused heterocyclic compoundsAMGEN INC·Filed 2003·Granted Aug 7, 2007·1 cites·35 claims
- 3663US6858619B2Fused heterocyclic compoundsAMGEN INC·Filed 2002·Granted Feb 22, 2005·3 cites·47 claims
- 3759US7125885B2Fused heterocyclic compoundsAMGEN INC·Filed 2004·Granted Oct 24, 2006·0 cites·2 claims
- 3858US2023158151A1Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3957US2024279202A1Compounds for inhibiting or degrading itk, compositions, comprising the same methods of their making and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4056US2008058365A1Fused heterocyclic compoundsAMGEN INC·Filed 2007·Application pending·0 cites
- 4154US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 4250US2007078152A1Piperidine derivativesAMGEN INC·Filed 2005·Application pending·0 cites
- 4350US2022324835A1Inhibitors of cbl-b and methods of use thereofNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4446US2007135425A1Fused heterocyclic compoundsAMGEN INC·Filed 2007·Application pending·0 cites
- 4544US2023024442A1Bifunctional compounds for grading btk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →